ITEMS IN AFP WITH KEYWORD:
Stroke and TIA
Apr 15, 2011 Issue
AHA/ASA Guidelines on Prevention of Recurrent Stroke [Practice Guidelines]
Persons who survive a stroke or transient ischemic attack (TIA) are at increased risk of experiencing another stroke. The American Heart Association (AHA) and the American Stroke Association (ASA) have released updated guidelines on preventing recurrent stroke in patients who have had a previous stroke or TIA.
Computed tomography (CT) is the diagnostic standard for acute stroke even though its accuracy has not been formally established. Its sensitivity for diagnosing ischemic stroke in the initial hours is limited; therefore, improved accuracy is needed to develop and provide optimal stroke treatment. The...
Apr 1, 2010 Issue
Effectiveness of B-Complex Vitamins for Prevention of Cardiovascular Events [Cochrane for Clinicians]
Eight randomized clinical trials that included 24,210 patients did not show a reduction in MI, stroke, or all-cause mortality with B-complex vitamin therapy.
Does telmisartan therapy after stroke prevent recurrence and adverse cardiovascular events? Despite lowering blood pressure, telmisartan did not provide preventative benefit. This study reflects problems with publication bias and that surrogate markers, such as blood pressure control, may not reflect patient outcomes.
Stroke can be categorized as ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Awakening with or experiencing the abrupt onset of focal neurologic deficits is the hallmark of ischemic stroke diagnosis. The most common presenting symptoms for ischemic stroke are difficulty with ...
Case study: K.A. is a 63-year-old man who presents for a routine wellness examination. His blood pressure and cholesterol level are within normal limits, and he has no history of tobacco use or heart disease.
Jun 15, 2008 Issue
Predicting Prognoses in Patients with Acute Stroke [Point-of-Care Guides]
A number of clinical decision models and scoring systems have been developed and validated to assist physicians in assessing the prognosis of patients with acute stroke.
Compared with antiplatelet therapy, oral anticoagulation significantly reduces stroke at an average follow-up of one to three years, but does not reduce mortality. Intracranial or extracranial hemorrhage is more common with anticoagulation and must be weighed against its therapeutic benefit.
Apr 1, 2008 Issue
Screening for Carotid Artery Stenosis: Recommendation Statement [U.S. Preventive Services Task Force]
This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on screening for carotid artery stenosis and the supporting scientific evidence, and updates the 1996 recommendations contained in the Guide to Clinical Preventive Services, 2nd ed.
Does the widespread use of the thrombolytic tissue plasminogen activator (t-PA) more beneficial or harmful in patients with acute stroke? The benefits must be balanced against the harms. Informed consent is necessary when making the decision.